{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:25:42Z","timestamp":1780428342199,"version":"3.54.1"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,2]]},"DOI":"10.1093\/jcag\/gwy050","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T23:27:30Z","timestamp":1536881250000},"page":"S34-S41","source":"Crossref","is-referenced-by-count":39,"title":["The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care"],"prefix":"10.1093","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-8426","authenticated-orcid":false,"given":"M Ellen","family":"Kuenzig","sequence":"first","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium, Ottawa, Ontario, Canada"},{"name":"Children\u2019s Hospital of Eastern Ontario IBD Centre, Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Lee","sequence":"additional","affiliation":[{"name":"McGill IBD Centre of Excellence, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"El-Matary","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium, Ottawa, Ontario, Canada"},{"name":"University of Manitoba IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam V","family":"Weizman","sequence":"additional","affiliation":[{"name":"Mount Sinai Hospital Centre for IBD, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-3598","authenticated-orcid":false,"given":"Eric I","family":"Benchimol","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium, Ottawa, Ontario, Canada"},{"name":"Children\u2019s Hospital of Eastern Ontario IBD Centre, Department of Pediatrics and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilaad G","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium, Ottawa, Ontario, Canada"},{"name":"Department of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium, Ottawa, Ontario, Canada"},{"name":"Mount Sinai Hospital Centre for IBD, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium, Ottawa, Ontario, Canada"},{"name":"University of Manitoba IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bitton","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium, Ottawa, Ontario, Canada"},{"name":"McGill IBD Centre of Excellence, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Lee","sequence":"additional","affiliation":[{"name":"Crohn\u2019s and Colitis Canada, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Cooke-Lauder","sequence":"additional","affiliation":[{"name":"Bataleur Enterprises Inc., Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K","family":"Murthy","sequence":"additional","affiliation":[{"name":"Canadian Gastro-Intestinal Epidemiology Consortium, Ottawa, Ontario, Canada"},{"name":"Ottawa Hospital Research Institute, Department of Medicine and School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"issue":"2","key":"2019042409562822500_CIT0001","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/14737167.2015.1011130","article-title":"Indirect health costs in ulcerative colitis and Crohn\u2019s disease: A systematic review and meta-analysis","volume":"15","author":"Kawalec","year":"2015","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2019042409562822500_CIT0002","first-page":"107","article-title":"Direct and indirect utilization and costs associated with ulcerative colitis","author":"Cohen","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"2019042409562822500_CIT0003","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/JOM.0b013e318181b8ca","article-title":"The direct and indirect cost burden of Crohn\u2019s disease and ulcerative colitis","volume":"50","author":"Gibson","year":"2008","journal-title":"J Occup Environ Med"},{"issue":"4","key":"2019042409562822500_CIT0004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004836-199206000-00009","article-title":"Inflammatory bowel disease: Costs-of-illness","volume":"14","author":"Hay","year":"1992","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"2019042409562822500_CIT0005","article-title":"The indirect costs of inflammatory bowel disease: Evidence from United States National Survey Data","volume":"138","author":"Lofland","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"2019042409562822500_CIT0006","doi-asserted-by":"crossref","first-page":"A26","DOI":"10.1016\/S0016-5085(09)60123-2","article-title":"Direct and indirect economic burdens and impact on salary growth of moderate to severe Crohn\u2019s disease","volume":"136","author":"Loftus","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"2019042409562822500_CIT0007","first-page":"1064","article-title":"Work losses related to inflammatory bowel disease in the United States: Results from the National Health Interview Survey","volume":"98","author":"Longobardi","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2019042409562822500_CIT0008","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1572-0241.2003.07378.x","article-title":"Work losses related to inflammatory bowel disease in Canada: Results from a National Population Health Survey","volume":"98","author":"Longobardi","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2019042409562822500_CIT0009","first-page":"A207","article-title":"Comparison of total health care expenditures and absenteeism for inflammatory bowel disease from an employer\u2019s perspective","volume":"13","author":"Naim","year":"2010","journal-title":"Value Health"},{"issue":"5","key":"2019042409562822500_CIT0010","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/S0016-5085(11)60827-5","article-title":"Economic impact of deep remission in adalimumab-treated patients with Crohn\u2019s disease: Results from extend","volume":"140","author":"Sandborn","year":"2011","journal-title":"Gastroenterology"},{"issue":"10","key":"2019042409562822500_CIT0011","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/gut.2004.041616","article-title":"Cost of illness of inflammatory bowel disease in the UK: A single centre retrospective study","volume":"53","author":"Bassi","year":"2004","journal-title":"Gut"},{"key":"2019042409562822500_CIT0012","first-page":"209","article-title":"Burden of Crohn\u2019s disease: Economics and quality of life aspects in Italy","volume":"4","author":"Benedini","year":"2012","journal-title":"Clinicoecon Outcomes Res"},{"issue":"11","key":"2019042409562822500_CIT0013","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3109\/00365529709002993","article-title":"Inflammatory bowel diseases: Health care and costs in Sweden in 1994","volume":"32","author":"Blomqvist","year":"1997","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"2019042409562822500_CIT0014","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.dld.2003.07.002","article-title":"Burden of illness of Crohn\u2019s disease in Spain","volume":"35","author":"Juan","year":"2003","journal-title":"Dig Liver Dis"},{"key":"2019042409562822500_CIT0015","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1007\/s10198-014-0613-5","article-title":"Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics","volume":"15","author":"Mandel","year":"2014","journal-title":"Eur J Health Econ"},{"issue":"12","key":"2019042409562822500_CIT0016","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ibd.20939","article-title":"Resource use and societal costs for Crohn\u2019s disease in Sweden","volume":"15","author":"Mesterton","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"2019042409562822500_CIT0017","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00019053-200624080-00006","article-title":"Costs of inflammatory bowel disease in Germany","volume":"24","author":"Stark","year":"2006","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"2019042409562822500_CIT0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","article-title":"Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFalpha therapy: Results from the COIN study","volume":"63","author":"van der Valk","year":"2014","journal-title":"Gut"},{"issue":"1349","key":"2019042409562822500_CIT0019","first-page":"11","article-title":"The cost of paediatric and perianal Crohn\u2019s disease in Canterbury, New Zealand","volume":"125","author":"Lion","year":"2012","journal-title":"N Z Med J"},{"key":"2019042409562822500_CIT0020","volume-title":"The Economic Costs of Crohn\u2019s Disease and Ulcerative Colitis","author":"Australian Crohn\u2019s and Colitis Association","year":"2017"},{"issue":"4","key":"2019042409562822500_CIT0021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/JOM.0b013e31827cba48","article-title":"The employee absenteeism costs of inflammatory bowel disease: Evidence from US National Survey Data","volume":"55","author":"Gunnarsson","year":"2013","journal-title":"J Occup Environ Med"},{"issue":"6","key":"2019042409562822500_CIT0022","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3111\/13696998.2015.1021353","article-title":"Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US","volume":"18","author":"Cohen","year":"2015","journal-title":"J Med Econ"},{"issue":"7","key":"2019042409562822500_CIT0023","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/MIB.0000000000000399","article-title":"Presenteeism in Inflammatory Bowel Diseases: A hidden problem with significant economic impact","volume":"21","author":"Zand","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2019042409562822500_CIT0024","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00043764-200101000-00005","article-title":"Alternative valuations of work loss and productivity","volume":"43","author":"Berger","year":"2001","journal-title":"J Occup Environ Med"},{"key":"2019042409562822500_CIT0025","article-title":"Association between IBD disability and reduced work productivity (Presenteeism): A population-based study in Manitoba, Canada","author":"Shafer","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"2019042409562822500_CIT0026","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cgh.2017.05.046","article-title":"Workplace accommodation for persons with IBD: What is needed and what is accessed","volume":"15","author":"Chhibba","year":"2017","journal-title":"Clin Gastroenterol H"},{"key":"2019042409562822500_CIT0027","volume-title":"Average weekly earnings (including overtime), by province and territory","author":"Statistics Canada","year":"2017"},{"key":"2019042409562822500_CIT0028","first-page":"A-29","article-title":"The rising prevalence of inflammatory bowel disease in Canada: Analyzing the past to predict the future","volume":"1","author":"Coward","year":"2018","journal-title":"JCAG"},{"issue":"11","key":"2019042409562822500_CIT0029","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.crohns.2014.06.006","article-title":"Sick leave and disability pension in inflammatory bowel disease: A systematic review","volume":"8","author":"Busch","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"6","key":"2019042409562822500_CIT0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00054725-200211000-00002","article-title":"The impact of inflammatory bowel disease on labor force participation: Results of a population sampled case-control study","volume":"8","author":"Boonen","year":"2002","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2019042409562822500_CIT0031","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00365521.2012.685750","article-title":"The burden of inflammatory bowel disease on health care utilization and quality of life","volume":"48","author":"Nurmi","year":"2013","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2019042409562822500_CIT0032","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ecco-jcc\/jjv041","article-title":"Patient-relevant endpoints in inflammatory bowel diseases\u2014have changes occurred in Germany over the past twelve years","volume":"9","author":"Stallmach","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2019042409562822500_CIT0033","volume-title":"Table 282-0051: Labour Fource Survey Estimates, Retirement Age by Class of Worker and Sex","author":"Statistics Canada","year":"2018"},{"key":"2019042409562822500_CIT0034","volume-title":"Germany retirement age\u2014men","author":"Trading Economics","year":"2018"},{"key":"2019042409562822500_CIT0035","volume-title":"Germany retirement age\u2014women","author":"Trading Economics","year":"2018"},{"issue":"9","key":"2019042409562822500_CIT0036","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1136\/gutjnl-2014-307983","article-title":"Predictors and risks for death in a population-based study of persons with IBD in Manitoba","volume":"64","author":"Bernstein","year":"2015","journal-title":"Gut"},{"issue":"2","key":"2019042409562822500_CIT0037","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MIB.0000000000000993","article-title":"Risk of surgery and mortality in elderly-onset inflammatory bowel disease: a population-based cohort study","volume":"23","author":"Nguyen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2019042409562822500_CIT0038","volume-title":"Table 102\u20130531--Deaths, by cause, Chapter XI: Diseases of the digestive system (K00 to K93), age group and sex, Canada, Annual","author":"Statistics Canada","year":"2017"},{"issue":"11","key":"2019042409562822500_CIT0039","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1155\/2012\/984575","article-title":"Inflammatory bowel disease: A Canadian burden of illness review","volume":"26","author":"Rocchi","year":"2012","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"2019042409562822500_CIT0040","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jpeds.2014.12.010","article-title":"Academic performance among children with inflammatory bowel disease: A population-based study","volume":"166","author":"Singh","year":"2015","journal-title":"J Pediatr"},{"issue":"9","key":"2019042409562822500_CIT0041","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/ibd.20484","article-title":"College adjustment in University of Michigan students with Crohn\u2019s and colitis","volume":"14","author":"Adler","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"2019042409562822500_CIT0042","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/01.mcg.0000159220.70290.41","article-title":"Unemployment and disability in patients with moderately to severely active Crohn\u2019s disease","volume":"39","author":"Feagan","year":"2005","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"2019042409562822500_CIT0043","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/MIB.0000000000000133","article-title":"The impact of moderate-to-severe Crohn\u2019s disease on employees\u2019 salary growth","volume":"20","author":"Loftus","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"2019042409562822500_CIT0044","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1097\/MIB.0000000000001268","article-title":"Indirect costs and family burden of pediatric Crohn\u2019s disease in the United States","volume":"23","author":"Kahn","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"2019042409562822500_CIT0045","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1007\/s10620-012-2289-y","article-title":"Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: Evidence from a US national survey","volume":"57","author":"Gunnarsson","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"6","key":"2019042409562822500_CIT0046","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct health care costs of Crohn\u2019s disease and ulcerative colitis in US children and adults","volume":"135","author":"Kappelman","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"2019042409562822500_CIT0047","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ibd.21360","article-title":"Use of complementary and alternative medicine by patients with inflammatory bowel disease","volume":"17","author":"Hilsden","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2019042409562822500_CIT0048","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gutjnl-2011-300219","article-title":"The Manitoba Inflammatory Bowel Disease Cohort Study: A prospective longitudinal evaluation of the use of complementary and alternative medicine services and products","volume":"61","author":"Rawsthorne","year":"2012","journal-title":"Gut"},{"issue":"7211","key":"2019042409562822500_CIT0049","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.319.7211.693","article-title":"What is complementary medicine","volume":"319","author":"Zollman","year":"1999","journal-title":"BMJ"},{"issue":"6","key":"2019042409562822500_CIT0050","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/MIB.0000000000000773","article-title":"Use of complementary and alternative medicine for inflammatory bowel disease is associated with worse adherence to conventional therapy: The COMPLIANT study","volume":"22","author":"Nguyen","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"2019042409562822500_CIT0051","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2036.2011.04956.x","article-title":"Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease","volume":"35","author":"Weizman","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2019042409562822500_CIT0052","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MEG.0000000000000040","article-title":"Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: Results from a French national survey","volume":"26","author":"Abitbol","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"2019042409562822500_CIT0053","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3109\/00365521.2012.725092","article-title":"Use of complementary and alternative medicine in patients with inflammatory bowel disease: Results of a cross-sectional study in Norway","volume":"47","author":"Opheim","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"2019042409562822500_CIT0054","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ctim.2013.12.001","article-title":"Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea","volume":"22","author":"Park","year":"2013","journal-title":"Complement Ther Med"},{"issue":"2","key":"2019042409562822500_CIT0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1155\/2015\/815820","article-title":"Living with inflammatory bowel disease: A Crohn\u2019s and Colitis Canada survey","volume":"29","author":"Becker","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"6","key":"2019042409562822500_CIT0056","first-page":"1368","article-title":"Out-of-pocket cost burden in pediatric inflammatory bowel disease: A cross-sectional cohort analysis","volume":"21","author":"Sin","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"2019042409562822500_CIT0057","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2007.03431.x","article-title":"Meta-analysis: Enteral nutrition in active Crohn\u2019s disease in children","volume":"26","author":"Dziechciarz","year":"2007","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcag\/article-pdf\/2\/Supplement_1\/S34\/28515290\/gwy050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T09:58:19Z","timestamp":1556099899000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/2\/Supplement_1\/S34\/5099125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":57,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2018,11,2]]},"published-print":{"date-parts":[[2019,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwy050","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,11,2]]}}}